P1521: A SEVERE MOUSE MODEL OF ALPHA-THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

por Rivella, S., Chappell, M., Jarocha, D., Breda, L., Ghiaccio, V., Fedorky, M., Triebwasser, M., Guerra, A., Gollomp, K., Teawtrakul, N., Glentis, S., Kattamis, A., Abdulmalik, O.
Publicado 2022

Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents

por Omar, A. M., David, T., Pagare, P. P., Ghatge, M. S., Chen, Q., Mehta, A., Zhang, Y., Abdulmalik, O., Naghi, A. H., El-Araby, M. E., Safo, M. K.
Publicado 2019

Clinical, metabolic, and molecular genetic characterization of hereditary methemoglobinemia caused by cytochrome b(5) reductase deficiency in 30 dogs

por Jaffey, J. A., Reading, N. S., Abdulmalik, O., Kreisler, R., Bullock, G., Wiest, A., Villani, N. A., Mhlanga-Mutangadura, T., Johnson, G. S., Cohn, L. A., Isaza, N., Harvey, J. W., Giger, U.
Publicado 2020